(Q43919658)

English

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

scientific article published in March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study (English)

1 reference

Europe PubMed Central

28 November 2017

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

0 references

2

1 reference

Europe PubMed Central

28 November 2017

Jens Juul Holst

4

1 reference

Europe PubMed Central

28 November 2017

1

object named as

Mette Zander

1 reference

Europe PubMed Central

28 November 2017

author name string

Jan Lysgaard Madsen

3

1 reference

Europe PubMed Central

28 November 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

359

1 reference

Europe PubMed Central

28 November 2017

824-830

1 reference

Europe PubMed Central

28 November 2017

9309

1 reference

Europe PubMed Central

28 November 2017

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of nutrient ingestion on glucagon-like peptide 1 (7-36 amide) secretion in human type 1 and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide-1 (GLP-1): a trial of treatment in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide-1 infusion must be maintained for 24 h/day to obtain acceptable glycemia in type 2 diabetic patients who are poorly controlled on sulphonylurea treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of weight loss on regional fat distribution and insulin sensitivity in obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of hepatic insulin action in obese type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Banting lecture 1990. Beta-cells in type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907952-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(02)07952-7

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43919658&oldid=2104393631"